Lotan Shilo

1.0k total citations
34 papers, 765 citations indexed

About

Lotan Shilo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrine and Autonomic Systems. According to data from OpenAlex, Lotan Shilo has authored 34 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in Lotan Shilo's work include Heart Failure Treatment and Management (8 papers), Sleep and related disorders (4 papers) and Circadian rhythm and melatonin (4 papers). Lotan Shilo is often cited by papers focused on Heart Failure Treatment and Management (8 papers), Sleep and related disorders (4 papers) and Circadian rhythm and melatonin (4 papers). Lotan Shilo collaborates with scholars based in Israel, United Kingdom and United States. Lotan Shilo's co-authors include S. Dolev, U. Weinberg, Elizabeth Shenkman, Louis Shenkman, Y. Dagan, Yaron Dagan, Dan Nabriski, Gili Solomon, Mia Shapiro and Menachem S. Shapiro and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Biochemical and Biophysical Research Communications and CHEST Journal.

In The Last Decade

Lotan Shilo

34 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lotan Shilo Israel 13 236 198 144 144 106 34 765
Iacopo Cancelli Italy 16 286 1.2× 79 0.4× 58 0.4× 66 0.5× 124 1.2× 27 1.1k
Andrew D. Calvin United States 21 324 1.4× 145 0.7× 316 2.2× 264 1.8× 549 5.2× 50 1.4k
Abdulhamid H. Samarkandi Saudi Arabia 20 76 0.3× 183 0.9× 169 1.2× 201 1.4× 111 1.0× 39 1.1k
Sophia E. J. A. de Rooij Netherlands 15 48 0.2× 707 3.6× 82 0.6× 47 0.3× 92 0.9× 33 1.1k
Annemarieke de Jonghe Netherlands 14 54 0.2× 344 1.7× 58 0.4× 46 0.3× 68 0.6× 37 643
Judith Bellapart Australia 13 35 0.1× 167 0.8× 90 0.6× 203 1.4× 72 0.7× 34 858
Laurence Brownell Canada 6 58 0.2× 45 0.2× 155 1.1× 93 0.6× 222 2.1× 7 557
I. M. James United Kingdom 14 62 0.3× 19 0.1× 73 0.5× 99 0.7× 76 0.7× 32 927
Carol A. Moote Canada 12 108 0.5× 91 0.5× 102 0.7× 101 0.7× 214 2.0× 18 949
Cristina D’Angelo Italy 13 31 0.1× 26 0.1× 133 0.9× 55 0.4× 184 1.7× 22 1.4k

Countries citing papers authored by Lotan Shilo

Since Specialization
Citations

This map shows the geographic impact of Lotan Shilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotan Shilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotan Shilo more than expected).

Fields of papers citing papers by Lotan Shilo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotan Shilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotan Shilo. The network helps show where Lotan Shilo may publish in the future.

Co-authorship network of co-authors of Lotan Shilo

This figure shows the co-authorship network connecting the top 25 collaborators of Lotan Shilo. A scholar is included among the top collaborators of Lotan Shilo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotan Shilo. Lotan Shilo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Topaz, Guy, David Pereg, Yona Kitay‐Cohen, et al.. (2020). Prediction of acute-coronary-syndrome using newly-defined R2-CHA2DS2-VASc score among patients with chest pain. Journal of Cardiology. 77(4). 370–374. 4 indexed citations
2.
Topaz, Guy, Alon Eisen, Alon Y. Hershko, et al.. (2018). Impaired renal function is associated with adverse outcomes in patients with chest pain discharged from internal medicine wards. European Journal of Internal Medicine. 53. 57–61. 4 indexed citations
3.
Topaz, Guy, Yona Kitay‐Cohen, David Pereg, et al.. (2018). Iodinated Contrast Media Allergy in Patients Hospitalized for Investigation of Chest Pain. The Journal of Allergy and Clinical Immunology In Practice. 6(6). 2059–2064. 7 indexed citations
5.
Topaz, Guy, et al.. (2017). The association between red cell distribution width and poor outcomes in hospitalized patients with influenza. Journal of Critical Care. 41. 166–169. 17 indexed citations
6.
Shilo, Lotan, et al.. (2017). Analysis of abbreviations used by residents in admission notes and discharge summaries. QJM. 111(3). 179–183. 13 indexed citations
7.
Ness-Abramof, R., Dan Nabriski, Menachem S. Shapiro, et al.. (2006). Prevalence and Evaluation of B12 Deficiency in Patients with Autoimmune Thyroid Disease. The American Journal of the Medical Sciences. 332(3). 119–122. 44 indexed citations
8.
Shilo, Lotan, et al.. (2002). The effects of coffee consumption on sleep and melatonin secretion. Sleep Medicine. 3(3). 271–273. 123 indexed citations
9.
Shilo, Lotan, et al.. (2002). Massive thyroid hormone overdose: kinetics, clinical manifestations and management.. PubMed. 4(4). 298–9. 24 indexed citations
10.
Shilo, Lotan, et al.. (2001). Appropriateness of Nitrate Use in a General Medicine Population. Annals of Pharmacotherapy. 35(11). 1339–1342. 2 indexed citations
11.
Shilo, Lotan, et al.. (2000). EFFECT OF MELATONIN ON SLEEP QUALITY OF COPD INTENSIVE CARE PATIENTS: A PILOT STUDY. Chronobiology International. 17(1). 71–76. 119 indexed citations
12.
Shilo, Lotan, et al.. (1999). Patients in the Intensive Care Unit Suffer from Severe Lack of Sleep Associated with Loss of Normal Melatonin Secretion Pattern. The American Journal of the Medical Sciences. 317(5). 278–278. 62 indexed citations
13.
Weinberg, U., S. Dolev, Moshe M. Werber, et al.. (1992). Identification and preliminary characterization of two human digitalis-like substances that are structurally related to digoxin and ouabain. Biochemical and Biophysical Research Communications. 188(3). 1024–1029. 14 indexed citations
14.
Varsano, Shabtai, et al.. (1992). Endogenous Digoxin-like Immunoreactive Factor Is Elevated in Advanced Chronic Respiratory Failure. CHEST Journal. 101(1). 146–149. 8 indexed citations
15.
Shilo, Lotan, S. Dolev, & Louis Shenkman. (1989). Atrial Natriuretic Peptide and Digoxin‐Like Factor in the Peripartum Period. The Journal of Clinical Pharmacology. 29(12). 1106–1107. 7 indexed citations
16.
Shilo, Lotan, A. Pomeranz, M. Rathaus, J. Bernheim, & Louis Shenkman. (1989). Endogenous digoxin-like factor raises blood pressure and protects against digitalis toxicity. Life Sciences. 44(24). 1867–1870. 9 indexed citations
17.
Wolach, Baruch, et al.. (1989). Endogenous Digoxin-Like Factor in Neonates: Effect of Age and Relation to Serum Bilirubin Levels. Acta Paediatrica. 78(3). 364–368. 10 indexed citations
18.
Shilo, Lotan, A. Pomeranz, M. Rathaus, et al.. (1988). Atrial natriuretic peptide administration to normal and salt depleted rats — Effects on digoxin-like immunoreactive factor, aldosterone, acth, and renal function. Life Sciences. 42(19). 1855–1859. 10 indexed citations
19.
Shilo, Lotan, et al.. (1987). Endogenous digoxin-like immunoreactivity in congestive heart failure.. BMJ. 295(6595). 415–416. 33 indexed citations
20.
Shilo, Lotan, Moshe M. Werber, S. Dolev, Mia Shapiro, & Elizabeth Shenkman. (1987). Digoxin-Like Immunoreactivity: Occurrence in Three Molecular Forms and Partial Characterization*. The Journal of Clinical Endocrinology & Metabolism. 64(6). 1257–1260. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026